Addressing the Cold Reality of mRNA Vaccine Stability

Hrabovszki Kansteiner Pollard, 2013, Challenges and advances towards the rational design of mRNA vaccines, Trends Mol Med, 19, 705, 10.1016/j.molmed.2013.09.002 Kowalski, 2019, Delivering the messenger: advances in technologies for therapeutic mRNA delivery, Mol Ther, 27, 710, 10.1016/j.ymthe.2019.02.012 Pardi, 2018, mRNA vaccines - a new era in vaccinology, Nat Rev Drug Discov, 17, 261, 10.1038/nrd.2017.243 Pogocki, 2000, Chemical stability of nucleic acid–derived drugs, J Pharm Sci, 89, 443, 10.1002/(SICI)1520-6017(200004)89:4<443::AID-JPS2>3.0.CO;2-W Mikkola, 2001, The effect of secondary structure on cleavage of the phosphodiester bonds of RNA, Cell Biochem Biophys, 34, 95, 10.1385/CBB:34:1:95 Wayment-Steele, 2020, Theoretical basis for stabilizing messenger RNA through secondary structure design, bioRxiv Reichmuth, 2016, mRNA vaccine delivery using lipid nanoparticles, Ther Deliv, 7, 319, 10.4155/tde-2016-0006 Hassett, 2019, Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines, Mol Ther Nucleic Acids, 15, 1, 10.1016/j.omtn.2019.01.013 Lutz, 2017, Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines, NPJ Vaccines, 2, 10.1038/s41541-017-0032-6 Sedic, 2018, Safety evaluation of lipid nanoparticle-formulated modified mRNA in the sprague-dawley rat and cynomolgus monkey, Vet Pathol, 55, 341, 10.1177/0300985817738095 Paris Kaczmarek, 2017, Advances in the delivery of RNA therapeutics: from concept to clinical reality, Genome Med, 9, 10.1186/s13073-017-0450-0 Muralidhara, 2016, Critical considerations for developing nucleic acid macromolecule based drug products, Drug Discov Today, 21, 430, 10.1016/j.drudis.2015.11.012 Jones, 2007, Long-term storage of DNA-free RNA for use in vaccine studies, Biotechniques, 43, 675, 10.2144/000112593 Stitz, 2017, A thermostable messenger RNA based vaccine against rabies, PLoS Negl Trop Dis, 11, e0006108, 10.1371/journal.pntd.0006108 Mutzke Mutzke Ketterer Panah Kievits Zhao, 2020, Long-term storage of lipid-like nanoparticles for mRNA delivery, Bioact Mater, 5, 358, 10.1016/j.bioactmat.2020.03.001 Naik, 2020, Regulatory considerations on the development of mRNA vaccines, 1, 10.1007/82_2020_220 Hinz, 2017, The European regulatory environment of RNA-based vaccines, 203 Schmid, 2017, Considerations for producing mRNA vaccines for clinical trials, 237 Poveda, 2019, Establishing preferred product characterization for the evaluation of RNA vaccine antigens, Vaccines (Basel), 7 Patel, 2017, Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA, Nano Lett, 17, 5711, 10.1021/acs.nanolett.7b02664 Middaugh, 2007, Analysis of cationic-lipid-plasmid-DNA complexes, Anal Chem, 79, 7240, 10.1021/ac0719711